Go Back

We Take Success Personally.

At Weaver, we care about success. But it’s not just the success of our firm or clients that matters to us; it’s the success of our people who make the day-to-day of this business possible. That’s why we’re passionate about bringing together talented individuals and giving them the tools they need to succeed. We lean on each other as members of the Weaver family, understanding that our culture is driven by our collective values, character and efforts. Our goal is to balance both high development with high performance in order to meet the long-term goals of each individual, team and our firm, and every person plays a part.

Weaver

Business Services

Beyond the Numbers: The Rebound and Current Financial State of the Biopharma and Med Tech Industries

MarketScale
January 12, 2022
acquisitions
biopharma
drugs
FDA
+more

 

COVID-19 rocked the world in most industries, but particularly for biopharma and pharmaceuticals, which were at the forefront. Tyler Ridley, Senior Manager of Valuation Services at Weaver, joined this episode of Weaver: Beyond The Numbers Podcast with Weaver hosts Howard Altshuler, Partner-In-Charge of Real Estate Services, and Rob Nowak, Tax Partner with Weaver, to discuss the rebound and current financial state of the biopharma and med tech industries.

Since the pandemic, the spike in healthcare initial public offerings (IPOs) and performance solidified the IPO pathway and exit strategy for life science investors. “I think it’s a shift in the narrative in biopharma and medical technology from profit-driven industries characterized by nefarious price gouging executives to more strategic industries that really came to the aid of the government and society more broadly in a time of crisis,” Ridley added.

While there were deal drop-offs in 2020 because of factors like the lack of elective surgeries, there was an increase in 2021 deals for digital therapeutics and delivery of care models. MedTech is just one example of this. “MedTech’s deal value has also exceeded 2020 totals so far and is on pace to be the highest value since 2017 despite a decline in total deal volume which indicates that the value per deal on average is increasing,” stated Ridley.

The M&A market has been muted this year, which is related to concerns with regulatory action to curb pricing power and lower drug prices. Risk tolerance to acquire other companies is not as favorable as it is to license their technology.

As for M&A activity for the rest of 2021, valuations are high, making it difficult for executives to gain acquisitions. The turbulent regulation environment combined with the lack of an FDA head is also hard to cope with. Additionally, the current supply chain issue may result in vertical acquisitions boosting M&A activity.

For more podcasts, whitepapers, and thought leadership on this topic, visit weaver.com.

Recent Episodes

pastor
View episode

Finding Purpose Through Service: Faith, Leadership, and Legacy with Pastor Arthur James

Burnout among faith leaders has surged in recent years, fueled by heavier workloads, complex community needs, and the quiet exhaustion many pastors carry—sparking urgent conversations about resilience, calling, and sustainable leadership. A survey found that roughly four in ten pastors considered leaving full-time ministry in a single year, citing reasons like stress and loneliness—making guidance…

Karen Alter
View episode

Why the Best Leaders Don’t Climb Straight Ladders: How Karen Alter Built Success Through Detours

As companies push to decarbonize, modernize infrastructure, and bring new technologies to market, the leaders who stand out aren’t always the ones who followed a straight career path. Increasingly, it’s the people with the zigzags—the folks who’ve worked across different industries, adapted to new environments, and learned to make decisions under pressure—who bring the clarity…

intuition
View episode

Allowing Inspiration to Grow from Intuition: How Inner Guidance Drives Real Career Growth

In a workplace culture increasingly shaped by rapid change, rising expectations, and new definitions of leadership, professionals are redefining success beyond titles and output. Empathy, intuition, and inner alignment — once seen as intangible “nice-to-haves” — are now emerging as competitive advantages. As recent workforce studies show that human-centered leaders drive higher engagement and…

Launch Your Branded Show Today

Engage your audience with original, industry-specific content.

Book a Demo Talk to an Expert